On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era

D. Busschots; R. Bielen; O.M. Koc; L. Heyens; E. Dercon; R. Verrando; F. Janssens; L. Van den Bergh; P. Van Lint; L. Bruckers; F. Nevens; G. Robaeys

doi:10.1186/s12889-021-11608-9

On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era

D. Busschots^*, R. Bielen, O.M. Koc, L. Heyens, E. Dercon, R. Verrando, F. Janssens, L. Van den Bergh, P. Van Lint, L. Bruckers, F. Nevens, G. Robaeys

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Article number	1574
Number of pages	9
Journal	BMC Public Health
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s12889-021-11608-9
Publication status	Published - 20 Aug 2021

Keywords

Hepatitis C
People who use drugs
Case management
Opioid agonist therapy
Care cascade
High-income country
INJECT DRUGS
GENERAL-PRACTICE
VIRUS-INFECTION
RANDOMIZED-TRIAL
PEOPLE
HCV
INTERVENTIONS
INTERFERON
SETTINGS
MODEL

Access to Document

10.1186/s12889-021-11608-9Licence: CC BY

Cite this

Busschots, D., Bielen, R., Koc, O. M., Heyens, L., Dercon, E., Verrando, R., Janssens, F., Van den Bergh, L., Van Lint, P., Bruckers, L., Nevens, F., & Robaeys, G. (2021). On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era. BMC Public Health, 21(1), [1574]. https://doi.org/10.1186/s12889-021-11608-9

@article{eb4da6aad09d41a0821e39dbe5f36202,

title = "On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era",

keywords = "Hepatitis C, People who use drugs, Case management, Opioid agonist therapy, Care cascade, High-income country, INJECT DRUGS, GENERAL-PRACTICE, VIRUS-INFECTION, RANDOMIZED-TRIAL, PEOPLE, HCV, INTERVENTIONS, INTERFERON, SETTINGS, MODEL",

author = "D. Busschots and R. Bielen and O.M. Koc and L. Heyens and E. Dercon and R. Verrando and F. Janssens and {Van den Bergh}, L. and {Van Lint}, P. and L. Bruckers and F. Nevens and G. Robaeys",

year = "2021",

month = aug,

day = "20",

doi = "10.1186/s12889-021-11608-9",

language = "English",

volume = "21",

journal = "BMC Public Health",

issn = "1471-2458",

publisher = "BioMed Central Ltd",

number = "1",

}

Busschots, D, Bielen, R, Koc, OM, Heyens, L, Dercon, E, Verrando, R, Janssens, F, Van den Bergh, L, Van Lint, P, Bruckers, L, Nevens, F & Robaeys, G 2021, 'On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era', BMC Public Health, vol. 21, no. 1, 1574. https://doi.org/10.1186/s12889-021-11608-9

On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era. / Busschots, D.; Bielen, R.; Koc, O.M.; Heyens, L.; Dercon, E.; Verrando, R.; Janssens, F.; Van den Bergh, L.; Van Lint, P.; Bruckers, L.; Nevens, F.; Robaeys, G.

In: BMC Public Health, Vol. 21, No. 1, 1574, 20.08.2021.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - On-site testing and case management to improve hepatitis C care in drug users: a prospective, longitudinal, multicenter study in the DAA era

AU - Busschots, D.

AU - Bielen, R.

AU - Koc, O.M.

AU - Heyens, L.

AU - Dercon, E.

AU - Verrando, R.

AU - Janssens, F.

AU - Van den Bergh, L.

AU - Van Lint, P.

AU - Bruckers, L.

AU - Nevens, F.

AU - Robaeys, G.

PY - 2021/8/20

Y1 - 2021/8/20

KW - Hepatitis C

KW - People who use drugs

KW - Case management

KW - Opioid agonist therapy

KW - Care cascade

KW - High-income country

KW - INJECT DRUGS

KW - GENERAL-PRACTICE

KW - VIRUS-INFECTION

KW - RANDOMIZED-TRIAL

KW - PEOPLE

KW - HCV

KW - INTERVENTIONS

KW - INTERFERON

KW - SETTINGS

KW - MODEL

U2 - 10.1186/s12889-021-11608-9

DO - 10.1186/s12889-021-11608-9

M3 - Article

C2 - 34416867

VL - 21

JO - BMC Public Health

JF - BMC Public Health

SN - 1471-2458

IS - 1

M1 - 1574

ER -